Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu’s Arteritis

Yixiao Tian, Biqing Huang, Jing Li, Xinping Tian, Xiaofeng ZengFrontiers in Immunology 2022 · DOI

TL;DR

This study reveals a novel connection between Toll-like Receptors (TLRs) and T-cell activation in Takayasu's Arteritis (TAK), a rare autoimmune disease. By analyzing gene expression and co-expression networks, researchers identified distinct TLR signaling patterns associated with disease activity and proposed TLR co-expression signatures as potential biomarkers.

What Problem Does This Paper Address?

Takayasu's Arteritis (TAK) is a serious autoimmune disease affecting large blood vessels, but the precise mechanisms driving its inflammation, particularly the interplay between the innate immune system and adaptive T-cells, remain poorly understood. While Toll-like Receptors (TLRs) are known to be involved in various autoimmune diseases, their specific role in TAK pathogenesis, especially concerning T-cell activation and disease activity, has been largely unexplored. This paper aims to bridge this knowledge gap by investigating the association between TLRs and T-cell activation in TAK patients, seeking to identify key molecular players and potential biomarkers for disease status.

Methods

The researchers employed a multi-pronged approach:

  • RT-qPCR: This standard technique was used to measure the mRNA abundance of 29 target genes, including various TLRs and genes involved in T-cell activation and differentiation, in peripheral blood mononuclear cells (PBMCs) from TAK patients and healthy controls.
  • Functional Enrichment Analysis: Databases like Gene Ontology (GO), KEGG, and WikiPathways were used to understand the biological functions and pathways associated with the selected genes.
  • Gene Co-expression Network Analysis: This was a key method, utilizing Pearson and Spearman correlations to build dynamic networks. This allowed the researchers to visualize how genes interact and to identify modules of genes that function together, revealing patterns of communication between TLRs and T-cells across different disease stages (untreated, treated inactive, treated active).
  • Unsupervised Hierarchical Clustering: This statistical technique was used to group samples based on their gene expression patterns, helping to distinguish between healthy controls and TAK patients, as well as between different disease states within TAK.
  • Correlation Analysis: Pearson and Spearman correlations were used to quantify the relationships between the expression levels of different genes, particularly focusing on inverse correlations between TLR gene clusters and T-cell activation gene clusters.
  • ROC Curve Analysis: Receiver Operating Characteristic (ROC) curves were used to evaluate the diagnostic accuracy of specific gene pairs (like TLR4-CCL5) as biomarkers for disease activity.
  • miRNA Sequencing and Analysis: Plasma exosomes were analyzed for miRNA content. This was followed by bioinformatic analysis using databases like miRDB and miRTarBase to predict miRNA-gene interactions and identify potential roles of miRNAs in the cross-talk between TLRs and T-cells.

Datasets

  • Peripheral Blood Mononuclear Cells (PBMCs): mRNA abundance data was collected from 27 TAK patients (further categorized into untreated, treated inactive, and treated active groups) and 10 healthy controls.
  • Plasma Exosomes: miRNA sequencing data was obtained from plasma exosomes of healthy controls and TAK patients.

Key Insights and Ideas

  • TLRs are Upregulated in TAK: Both untreated and treated TAK patients showed increased mRNA levels of TLR2 and TLR4 compared to healthy controls, suggesting a general involvement of these receptors in the disease.
  • Distinct Gene Expression Patterns: TAK patients, as a group, exhibited a different gene expression profile compared to healthy individuals, with 80% of healthy controls being distinguishable from TAK patients based on the selected genes.
  • Inverse Correlation in Inactive TAK: A striking finding was the unique pattern of inverse correlations observed in the inactive-treated TAK group between TLR gene clusters and T-cell activation/differentiation gene clusters. This suggests a complex regulatory mechanism where TLR activity might be suppressed or inversely related to T-cell activation in a quiescent disease state.
  • Active Communication in TAK: Gene co-expression networks revealed more active communication between TLRs and T-cell activation pathways in TAK patients (both active and inactive) compared to healthy controls.
  • TLR-Co-expression Signatures as Biomarkers: The study proposed that specific co-expression patterns of TLRs, such as the TLR4-TLR6 pair, could serve as biomarkers for disease activity in treated TAK patients, demonstrating high diagnostic accuracy.
  • miRNAs as Regulators of TLR-T-cell Cross-talk: miRNA sequencing identified specific miRNAs (particularly the miR-548 family) that may play a crucial role in regulating the interaction between TLRs and T-cells, especially in the inactive stage of TAK.

Key Results

  • Increased TLR2 and TLR4 mRNA: Untreated and treated TAK patients showed significantly higher mRNA levels of TLR2 and TLR4 compared to healthy controls.
  • Sample Separation: Hierarchical clustering analysis showed that 80% of healthy controls could be separated from TAK patients based on the expression of the 29 target genes.
  • Biomarker Performance: The co-expression of TLR4 and TLR6 demonstrated a high diagnostic accuracy for disease activity in treated TAK patients, with an Area Under the Curve (AUC) of 0.919, 100% sensitivity, and 90.9% specificity.
  • Inverse Correlation Pattern: The inactive-treated TAK group showed a distinct pattern of inverse correlations between TLR gene clusters and T-cell activation/differentiation gene clusters, which was absent in the active-treated TAK group.
  • miRNA Involvement: Several miRNAs, including the miR-548 family, miR-584, miR-3613, and miR-335, were identified as potentially playing a significant role in the cross-talk between TLRs and T-cells in TAK.

Limitations and Future Work

  • Sample Size: The authors acknowledge that the sample size, particularly for subgroup analysis (e.g., active vs. inactive groups), was relatively small, which may limit the generalizability of findings and the ability to separate subgroups definitively.
  • Correlation vs. Causation: While the study identified correlations, it cannot definitively establish causal relationships between TLRs and T-cell activation. Further experimental validation is needed.
  • Reference Genes: The influence of reference genes on correlation analysis results is noted as a potential limitation, though combining Pearson and Spearman correlations was used to mitigate this.
  • Further Validation: Larger clinical studies are needed to validate the findings and calibrate diagnostic thresholds.
  • Mechanistic Elucidation: The precise mechanisms underlying the observed inverse correlations between TLRs and T-cell activation in inactive TAK require deeper investigation.
  • Experimental Data: The authors suggest collecting experimental data on T-cell activation markers and cytokines to build more detailed models of the TLR-T-cell association.
  • miRNA Functionality: While miRNAs were identified, their precise functional roles and mechanisms of action in the TLR-T-cell cross-talk in TAK need further validation.
  • Naïve TAK Patients: The study did not include naïve TAK patients (those never treated), and it is suggested that their co-expression networks might differ from treated patients.

Summary updated

Abstract

To explore the relationships between Toll-like receptors (TLRs) and the activation and differentiation of T-cells in Takayasu's arteritis (TAK), using real-time fluorescence quantitative polymerase chain reaction, mRNA abundance of 29 target genes in peripheral blood mononuclear cells (PBMCs) were detected from 27 TAK patients and 10 healthy controls. Compared with the healthy control group, the untreated TAK group and the treated TAK group had an increased mRNA level of TLR2 and TLR4. A sample-to-sample matrix revealed that 80% of healthy controls could be separated from the TAK patients. Correlation analysis showed that the inactive-treated TAK group exhibited a unique pattern of inverse correlations between the TLRs gene clusters (including TLR1/2/4/6/8, BCL6, TIGIT, NR4A1, <i>etc</i>) and the gene cluster associated with T-cell activation and differentiation (including TCR, CD28, T-bet, GATA3, FOXP3, CCL5, <i>etc</i>). The dynamic gene co-expression network indicated the TAK groups had more active communication between TLRs and T-cell activation than healthy controls. BCL6, CCL5, FOXP3, GATA3, CD28, T-bet, TIGIT, IκBα, and NR4A1 were likely to have a close functional relation with TLRs at the inactive stage. The co-expression of TLR4 and TLR6 could serve as a biomarker of disease activity in treated TAK (the area under curve/sensitivity/specificity, 0.919/100%/90.9%). The largest gene co-expression cluster of the inactive-treated TAK group was associated with TLR signaling pathways, while the largest gene co-expression cluster of the active-treated TAK group was associated with the activation and differentiation of T-cells. The miRNA sequencing of the plasma exosomes combining miRDB, DIANA-TarBase, and miRTarBase databases suggested that the miR-548 family miR-584, miR-3613, and miR-335 might play an important role in the cross-talk between TLRs and T-cells at the inactive stage. This study found a novel relation between TLRs and T-cell in the pathogenesis of autoimmune diseases, proposed a new concept of TLR-co-expression signature which might distinguish different disease activity of TAK, and highlighted the miRNA of exosomes in TLR signaling pathway in TAK.
BibTeX
@inproceedings{tian2022identification,
  author = {Yixiao Tian and Biqing Huang and Jing Li and Xinping Tian and Xiaofeng Zeng},
  title = {{Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu’s Arteritis}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2021.792901},
}
Figure